Publication | Open Access

Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen

VaccinationTumor ImmunologyImmunologyTumor ImmunityTumor-associated AntigensTherapeutic VaccineCtl ResponsesModel Tumor/self AntigenCancer VaccinesVaccine DesignImmunotherapyMedicineRadiation OncologyTumor Microenvironment